New Delhi [India], June 19 (ANI): The Drug Controller General of India (DCGI) has granted permission to anti-viral drug favipiravir for "restricted emergency use" in mild to moderate cases of COVID-19, a senior government official confirmed to ANI.
New Delhi [India], May 8 (ANI): The Council for Scientific and Industrial Research (CSIR) has received approval from Drug Controller General of India (DGCI) for its two clinical trial drugs - 'favipiravir' and 'phytopharmaceutical' - to combat coronavirus.
New Delhi [India], May 7 (ANI): The Council for Scientific and Industrial Research (CSIR) is exploring a native herb as a biological medicine or "phytopharmaceutical ", which is already being tested as medicine for dengue, for its efficacy to combat COVID-19.
New Delhi [India], Mar 20 (ANI): The Drug Controller General of India (DCGI) has given test licence to 18 companies including international and private companies to conduct coronavirus (COVID-19) tests in India.
New Delhi [India], Mar 20 (ANI): Amid coronavirus pandemic, the central government has banned the operations of international commercial passenger flights in India from March 22 to March 29.